Entact Bio Launches with $81 Million Series A to Develop Pre

Launch fueled by syndicate of blue-chip investors co-led by Qiming Venture Partners USA and venBio PartnersCompany’s proprietary end-to-end Encompass™ platform designs enhancement-targeting chimeric (ENTAC™) moleculesFounding team comprised of world-class scientific leadersWATERTOWN, Mass.--(BUSINESS WIRE)--Entact B...

Related Keywords

Ueli Nachbur , Entact Bio , Michael Clague , Colin Walsh , Jarrod Marto , Sara Buhrlage , David Komander , David Sheppard , Richard Gaster , Linkedin , Twitter , Harvard Medical School , Sheppard Rd Consultancy Ltd , University Of Liverpool , Eliza Hall Institute Of Medical Research , Head Of The Ubiquitin Signalling Division , Dana Farber Cancer Institute , Qiming Venture Partners United States , Bio Partners , Brandon Capital , Janus Henderson Investors , Logos Capital , Surveyor Capital , Eliza Hall Institute , Medical Research , Arkin Bio , Victoria Richon , Ribon Therapeutics , Associate Professor , Cellular Physiology , Ubiquitin Signalling Division , Scientist Entrepreneur , Sheppard Rd Consultancy , Qiming Venture ,